Everything below concerns Maleimide chemistry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-04. Numbers and descriptions here follow the published literature rather than marketing material.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
| Property | Value | Notes |
|---|---|---|
| Duration with linker | Several days | Reported in early human work |
| Duration without linker | Tens of minutes | Short plasma residence |
| Albumin attachment site | Cysteine-34 | Covalent maleimide reaction |
| Primary receptor | Pituitary GHRH receptor | Stimulates growth hormone release |
| Downstream marker | Insulin-like growth factor 1 | Indirect measure of activity |
High levels of prolactin are uncommon in people with gynecomastia. If β-hCG levels are abnormally high, then ultrasound of the testicles should be performed to check for signs of a hormone-secreting testicular tumor. Markers of testicular, adrenal, or other tumors, such as urinary 17-ketosteroid or serum dehydroepiandrosterone, may also be checked if there is evidence of hormonal imbalance on physical examination. If this evaluation does not reveal the cause of gynecomastia, it is considered to be idiopathic gynecomastia (of unclear cause).
An erection is the stiffening and rising of the penis, which occurs during sexual arousal, though it can also happen in non-sexual situations. Spontaneous erections frequently occur during adolescence due to friction with clothing, a full bladder or large intestine, hormone fluctuations, nervousness, and undressing in a nonsexual situation. It is also normal for erections to occur during sleep and upon waking. (See nocturnal penile tumescence.) The primary physiological mechanism that brings about erection is the autonomic dilation of arteries supplying blood to the penis, which allows more blood to fill the three spongy erectile tissue chambers in the penis, the corpora cavernosa and corpus spongiosum, causing it to lengthen and stiffen. After vasocongestion, the now-engorged erectile tissue presses against and constricts the veins that carry blood away from the penis. More blood enters than leaves the penis until an equilibrium is reached where an equal volume of blood flows into the dilated arteries and out of the constricted veins; a constant erectile size is achieved at this equilibrium. Erection facilitates sexual intercourse though it is not essential for various other sexual activities.
=== October === 1 October – In a televised address from Downing Street, Prime Minister Sir Keir Starmer condemns Iran's missile attack on Israel and says that Britain "stand[s] with Israel and ... [recognises] her right to self-defence in the face of this aggression". 2 October – Starmer makes his first visit to Brussels as prime minister, where he is attempting to rebuild UK–EU relations. It is reported that Starmer has repaid £6,000 in gifts and hospitality received since becoming prime minister. The Parliamentary Commission on Standards has launched an investigation into Labour peer Lord Alli over allegations of failing to register interests. 3 October – The UK announces that it will give up sovereignty of the Chagos Islands to Mauritius, subject to finalisation of a treaty. BBC presenter Laura Kuenssberg cancels a scheduled televised interview with Boris Johnson after accidentally sending him her briefing notes. Labour MP Kim Leadbeater announces plans to introduce a bill on assisted dying after earlier being selected to put forward a private member's bill. 4 October – GB News loses a High Court challenge against Ofcom in which it hoped to temporarily block the regulator from sanctioning it over its People's Forum programme featuring Rishi Sunak in February, while Sunak was prime minister. GB News is given permission to challenge the ruling, with Ofcom agreeing to hold off publication of its findings until the case is heard.
Like many other color additives, the primary use of Blue No. 1 is to correct or enhance natural coloring or to give colorless compounds a vivid hue. In the United States, of the two approved blue food dyes (the other being Indigo carmine, or FD&C Blue #2), brilliant blue FCF is the more common of the two. As a blue color, brilliant blue FCF is often found in cotton candy, ice cream, canned processed peas, packet soups, bottled food colorings, icings, ice pops, blueberry flavored products, children's medications, dairy products, sweets soft drinks, and drinks, especially the liqueur Blue Curaçao. It is also used in soaps, shampoos, mouthwash and other hygiene and cosmetics applications. Brilliant blue FCF is extensively used as a water tracer agent. Due to its ability to retain color for long periods of time, brilliant blue FCF outperforms other dye tracers. Additionally, brilliant blue FCF has a low toxicity level that is favorable for the environment. However, brilliant blue FCF has different impacts on varying soils. Brilliant blue FCF is attracted to and sorbed in acidic soils due to its large size and ionic charge. Soil composition and flow velocity also affect the level of sorption of brilliant blue FCF. Brilliant blue FCF dye within beverages items—such as soda—can be used in the blue bottle experiment. In such foods, both the dye and reducing agents are incorporated in the same solution. When the solution is blue, oxygen is present. On the addition of NaOH, a reaction occurs that removes the oxygen, turning the solution clear.
== External links == Spallation Neutron Source Mercury 197 Mercury 197 decays to Gold 197 Kolarik, Zdenek; Renard, Edouard V. (2003). "Recovery of Value Fission Platinoids from Spent Nuclear Fuel. Part I PART I: General Considerations and Basic Chemistry" (PDF). Platinum Metals Review. 47 (2): 74–87. doi:10.1595/003214003X4727487. Archived from the original (PDF) on 2011-06-09. Kolarik, Zdenek; Renard, Edouard V. (2003). "Recovery of Value Fission Platinoids from Spent Nuclear Fuel. Part II: Separation Process" (PDF). Platinum Metals Review. 47 (2): 123–131. doi:10.1595/003214003X473123131. Archived from the original (PDF) on 2011-06-09. Kolarik, Zdenek; Renard, Edouard V. (2005). "Potential Applications of Fission Platinoids in Industry". Platinum Metals Review. 49 (2): 79. doi:10.1595/147106705X35263.
Sources: en.wikipedia.org
Antidepressant discontinuation syndrome, or antidepressant withdrawal, is a condition that can occur following switching, reducing, or discontinuing an antidepressant medication following its continuous use of at least a month. The symptoms may include dizziness, vertigo, postural orthostatic tachycardia syndrome (POTS), tinnitus, insomnia, nausea, poor balance, sensory changes, "brain zaps", emotional lability or extreme emotional changes, rage, suicidal ideation, akathisia, dysesthesia, intrusive thoughts, depersonalization and derealization, mania, anxiety, depression, stuttering, and flu-like symptoms. Psychosis may rarely occur. Depending on the specific antidepressant's half-life, withdrawal can begin within a few days or weeks, but late onset or delayed onset withdrawal can occur months after cessation. If stopped too quickly, a withdrawal injury can occur. This is referred to as protracted withdrawal and may last for several months or years. Discontinuation syndrome was coined by Eli Lilly as a way to distance antidepressants from other dependence-forming psychotropics with higher addiction risk profiles. However, the evidence supports that what has been mislabeled as discontinuation syndrome is a classical withdrawal syndrome similar to that of benzodiazepines. Antidepressants are not addictive and do not produce substance use disorders, but they do create physical dependence which occurs when the body makes neuroadaptations due to the presence of the drug.
The Southern Rhodesian economy grew considerably during the war despite the concurrent rise of war expenditure to pay for the expansion of the military and the air training scheme. Expenditure on the war grew from £1,793,367 in the financial year 1940–41 to £5,334,701 in 1943–44—total Southern Rhodesian expenditure on the air training scheme was £11,215,522. These sums, while tiny compared to those incurred by larger nations, were enormous when scaled against the white population of less than 70,000 that accounted for most of the colony's economic output. Annual costs for the air training scheme alone far exceeded the pre-war national budget. Southern Rhodesia was then the second largest gold producer in the world, after South Africa. The colony's gold output had expanded greatly during the 1930s, and it remained the territory's main source of income during the war, though many extracting operations were diverted towards strategic minerals, most prominently chrome and asbestos. Southern Rhodesia became one of the two main sources of chrome for the Allies (South Africa was the other) and the world's third largest producer of asbestos after Canada and the Soviet Union. By the end of the war the mines at Shabani and Mashaba were turning out 1.5 million tonnes of asbestos a year, in addition to 600,000 tonnes of chrome. Gold output reached peak levels in 1941–42 and thereafter subsided. Southern Rhodesia also exported tungsten, mica and tin, and provided coal for the copper mines of Northern Rhodesia and the Congo.
Mattie Stepanek, a poet, peace advocate, and motivational speaker who had dysautonomic mitochondrial myopathy, and who died at age 13. Rocco Baldelli, a coach and former center fielder in Major League Baseball who had to retire from active play at age 29 due to mitochondrial channelopathy. Charlie Gard, a British boy who had mitochondrial DNA depletion syndrome; decisions about his care were taken to various law courts. Charles Darwin, a nineteenth century naturalist who suffered from a disabling illness, is speculated to have had MELAS syndrome.
In nuclear physics, the Geiger–Nuttall law or Geiger–Nuttall rule relates the decay constant of a radioactive isotope with the energy of the alpha particles emitted. Roughly speaking, it states that short-lived isotopes emit more energetic alpha particles than long-lived ones. The relationship also shows that half-lives are exponentially dependent on decay energy, so that very large changes in half-life make comparatively small differences in decay energy, and thus alpha particle energy. In practice, this means that alpha particles from all alpha-emitting isotopes across many orders of magnitude of difference in half-life, all nevertheless have about the same decay energy. Formulated in 1911 by Hans Geiger and John Mitchell Nuttall as a relation between the decay constant and the range of alpha particles in air, in its modern form the Geiger–Nuttall law is
Sources: en.wikipedia.org
Leucine-rich repeat protein SHOC-2 is a protein that in humans is encoded by the SHOC2 gene. This protein was initially identified in Caenorhabditis elegans as SUR-8/SOC2 and was found to be a critical positive regulator of the ERK1/2 signaling pathway that integrates the Ras and RAF components of the ERK1/2 pathway into a multiprotein complex. Specifically, SHOC2 tethers RAS and PP1C proteins and in close proximity to RAF to dephosphorylate “S259” to enable MAPK signaling. The best-studied role of SHOC2 is in modulating signals of the extracellular signal-regulated kinase 1 and 2 (ERK1/2) pathway by forming a holophosphatase complex that activates RAF proteins.
Midazolam, sold under the brand name Versed among others, is a benzodiazepine medication used for anesthesia, premedication before surgical anesthesia, and procedural sedation, and to treat severe agitation. It induces sleepiness, decreases anxiety, and causes anterograde amnesia. The drug does not cause an individual to become unconscious, merely to be sedated. It is also useful for the treatment of prolonged (lasting over five minutes) seizures. Midazolam can be given by mouth, intravenously, by injection into a muscle, by spraying into the nose, or through the cheek. When given intravenously, it typically begins working within five minutes; when injected into a muscle, it can take fifteen minutes to begin working; when taken orally, it can take 10–20 minutes to begin working. Side effects can include a decrease in efforts to breathe, low blood pressure, and sleepiness. Tolerance to its effects and withdrawal syndrome may occur following long-term use. Paradoxical effects, such as increased activity, can occur especially in children and older people. There is evidence of risk when used during pregnancy but no evidence of harm with a single dose during breastfeeding. Midazolam was patented in 1974 and came into medical use in 1982. It is on the World Health Organization's List of Essential Medicines. Midazolam is available as a generic medication. In many countries, it is a controlled substance.
=== Pharmacodynamics === In vitro, cannabidiol has low affinity for, and acts as a negative allosteric modulator of the CB1 cannabinoid receptor Cannabidiol may be an antagonist of GPR55, a G protein-coupled receptor and putative non-homologous CB3 cannabinoid receptor shown by in vitro studies to be widely distributed in the brain. Cannabidiol may interact with various neurotransmitters, such as serotonin, dopamine, and GABA. As of 2024, the cellular effects and mechanisms of cannabidiol in vivo are unknown, as research to date has been inconclusive and based on laboratory studies. The anticonvulsant effects provided by cannabidiol (Epidiolex) in people with certain forms of epilepsy do not appear to involve cannabinoid receptors. A possible mechanism for the effects of cannabidiol on seizures is by affecting the neuronal movement of calcium in brain structures involved in the excessive electrical activity of seizures.
Sources: en.wikipedia.org
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.
The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.
Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.